Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01350 (
gastrin
)
9,683
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The effects of ethanol and wine on serum
gastrin
concentration and gastric acid secretion were evaluated in 13 normal volunteers. Solutions studied were pure ethanol (5%, 12%, and 36%), red wine, and white wine. Each solution contained 28 g of ethanol and each was administered as a slow, steady intragastric infusion to simulate normal ingestion of beverages. When compared to saline (control), none of the pure ethanol solutions increased serum
gastrin
concentration or gastric acid secretion significantly. In contrast, red and white wine (12% ethanol vol/vol) were potent stimulants of
gastrin
release and acid secretion when compared either to saline or pure 12% ethanol. Mean (+/-
SEM
) peak serum
gastrin
increases with 300 ml of red wine, white wine, saline, and pure 12% ethanol were 253 +/- 125, 182 +/- 91, 13 +/- 2, and 11 +/- 3 pg/ml, respectively (p less than 0.05 for red and white wine versus saline or 12% ethanol), and the mean peak acid outputs were 28.6 +/- 2.8, 27.9 +/- 1.9, 9.3 +/- 2.0, and 11.9 +/- 1.3 mmol/h, respectively (p less than 0.05 for red and white wine versus saline or 12% ethanol). We conclude that red and white wine stimulate gastric acid secretion, probably by enhanced release of
gastrin
, and that this effect is not due to the ethanol content of wine.
...
PMID:Effect of intragastric infusions of ethanol and wine on serum gastrin concentration and gastric acid secretion. 377 Mar 65
Gastric secretion is supposed to be calcium-dependent. The effect of verapamil (0.3 mg/kg/h i.v.), a calcium channel-blocking agent, on stimulated gastric acid secretion and
gastrin
release was investigated in 8 mongrel dogs. Stimulation was either performed by bombesin (1.0 microgram/kg/h i.v.) or by insulin (0.3 U/kg i.v.). Verapamil significantly inhibited both the bombesin- and the insulin-stimulated gastric acid secretion. Mean total gastric acid output over a 120-min period was 9.5 +/- (
SEM
) 2.2 mmol after bombesin stimulation and 6.3 +/- 2.0 mmol after bombesin and verapamil (p less than 0.01). The respective values were 15.3 +/- 2.0 mmol for insulin stimulation and 7.0 +/- 1.6 mmol for insulin and verapamil (p less than 0.01). There was no significant influence of verapamil on plasma
gastrin
concentrations. Thus, the impairment of acid secretion by verapamil is not due to an inhibition of
gastrin
release in intact dogs.
...
PMID:Influence of verapamil on gastric acid secretion and gastrin release in dogs. 390 67
The sulfation of
gastrin
in serum, antrum and duodenum was studied in 22 normo- and 20 hypergastrinemic patients. The ratio between
gastrin
-17 and
gastrin
-34 was measured in antrum and duodenum. The degree of sulfation was reduced in the antrum of hypergastrinemic patients (35.3 +/- 1.3%, mean +/-
SEM
) compared with 48.0 +/- 2.1% in normo-gastrinemic patients (p less than 0.001). The degree of sulfation in serum and duodenum was similar to that of the antral gastrins in all patients. The percentage of
gastrin
-34 in antrum was increased (7.3 +/- 0.7%) in hypergastrinemic compared with 4.9 +/- 0.3% in normogastrinemic patients (p less than 0.01). In the duodenum the percentage of
gastrin
-34 was similar in normo- and hypergastrinemia. When classified according to clinical diagnosis, sulfation of antral
gastrin
was normal in duodenal ulcer (47.6 +/- 4.5%) but decreased in gastric ulcer (36.7 +/- 1.6%, p less than 0.01) and pernicious anemia (31.3 +/- 1.9%, p less than 0.001) compared with 48.2 +/- 2.2% in control patients. In pernicious anemia a larger proportion of antral gastrins occurred as
gastrin
-34 (8.2 +/- 0.9%) compared with 4.8 +/- 0.4% in control patients (p less than 0.01). Our study suggests that both sulfation and proteolytic processing of the
gastrin precursor
is diminished in hypergastrinemia of antral origin.
...
PMID:Decreased sulfation of serum and tissue gastrin in hypergastrinemia of antral origin. 397 77
The degree of tyrosine sulfation and the distribution between
gastrin
-17- and
gastrin
-34-like immunoreactivity (LI) were studied in the antra of ten mammalian species. Specific radioimmunoassays, gel-, and ion-exchange chromatography as well as enzymatic cleavage with trypsin and arylsulfatase were used. The percentage of sulfation varied from 24.4 +/- 4.2 (mean +/-
SEM
) in dogs to 80.1 +/- 2.6 in sheep, 46.8 +/- 3.3 in humans, 50.1 +/- 3.2 in cows, 55.9 +/- 2.3 in rats, 57.4 +/- 3.1 in pigs, 61.3 +/- 2.2 in guinea pigs, 64.1 +/- 4.7 in cats, 64.8 +/- 2.1 in mice and 68.2 +/- 2.8 in rabbits.
Gastrin-34
-LI in antral extracts could be converted to
gastrin
-17-LI by trypsin in all species. Five percent of antral gastrins eluted as
gastrin
-34-LI in all species. We conclude that while the ratio of
gastrin
-34-LI to
gastrin
-17-LI varies little in mammals, large differences occur in the degree of sulfation.
...
PMID:Species variation in the tyrosine sulfation of mammalian gastrins. 398 36
Beside intraluminal factors, humoral agents play an important role in intestinal adaptation. Enteroglucagon, the mucosal concentration of which is maximal in the terminal ileum and colon, is the strongest candidate for the role of small intestinal mucosal growth factor. The present experiment was designed to study the role of colonic enteroglucagon in stimulating mucosal growth in rats with a normal small intestine. After eight days of glucose large bowel perfusion, enteroglucagon plasma concentrations were 120.7 +/-
SEM
9.2 pmol/l, versus 60.1 +/- 6.8 in mannitol perfused control rats (p less than 0.001).
Gastrin
, cholecystokinin, neurotensin, pancreatic glucagon, and insulin plasma concentrations were unchanged. Crypt cell proliferation, measured by the vincristine metaphase arrest technique, increased significantly in the small intestine of glucose perfused animals (p less than 0.005-0.001) in comparison with the controls. This resulted in a greater mucosal mass in both proximal and distal small bowel: mucosal wet weight, DNA, protein and alpha D-glucosidase per unit length intestine were all significantly higher (p less than 0.05-0.001) than in mannitol perfused rats. Our data, therefore, support the hypothesis that enteroglucagon is an enterotrophic factor and stress the possible role of the colon in the regulation of small bowel trophicity.
...
PMID:Hyperenteroglucagonaemia and small intestinal mucosal growth after colonic perfusion of glucose in rats. 399 42
Sera from 15 patients with the Zollinger-Ellison syndrome were subjected to gel filtration on Sephadex G-50 superfine columns (10 x 2000 mm). The concentration of
gastrin
in the effluent was determined by a sensitive radioimmunoassay. Immunoreactive
gastrin
was eluted in four components in 14 sera. (1) Component I, eluted in the same position as proinsulin, constituted 9.7 +/- 1.2 (mean +/-
SEM
)% of the total immunoreactivity. (2) Component II (;
big gastrin
') eluted between proinsulin and insulin constituted 57.8 +/- 4.1% (mean +/-
SEM
) of immunoreactive
gastrin
. In three sera with the highest concentration of
gastrin
, component II appeared biphasic. (3) Component III (;little
gastrin
') was distributed in two peaks; the first one eluted in the same position as the heptadecapeptide
gastrin
II made up 17.4 +/- 2.7 (mean +/-
SEM
)% of the total immunoreactivity; the second one eluted in the same position as
gastrin
I constituted 9.5 +/- 1.3 (mean +/-
SEM
)%. (4) Component IV (;minigastrin') was eluted immediately before the salt peak and constituted 5.6 +/- 1.4 (mean +/-
SEM
)%. In one serum only components I and II were present. After incubation with trypsin all immunoreactivity in components I and II was converted to heptadecapeptide-like gastrins.The findings suggest that immunoreactive
gastrin
in serum from Zollinger-Ellison patients is circulating in at least four components of different molecular size.
...
PMID:Gel filtration studies on immunoreactive gastrin in serum from Zollinger-Ellison patients. 419 48
The effect of
gastrin
on basal- and glucose-stimulated insulin secretion was studied in 32 normal, young subjects. The concentration of
gastrin
and insulin in serum was measured radioimmunochemically. Maximal physiologic limit for the concentration of
gastrin
in serum was of the order of 160 pmol per liter as observed during a protein-rich meal. Oral ingestion of 50 g glucose produced a small
gastrin
response from 28+/-3 to 39+/-5 pmol per liter (mean +/-
SEM
, P < 0.01). Intravenous injection or prolonged infusion of
gastrin
increased the concentration of insulin in peripheral venous blood to a maximum within 2 min followed by a decline to basal levels after a further 10 min. The minimum dose required to induce a significant insulin response (31.2 ng
gastrin
per kg) increased the
gastrin
level in serum above the physiologic range. Maximum effect was obtained with 500 ng
gastrin
per kg. When 15.6 ng (7.1 pmol)
gastrin
per kg body weight and 25 g glucose were injected simultaneously, the glucose-induced insulin response was potentiated (from 2.32+/-0.33 to 4.33+/-0.98 nmol per liter per 20 min, P < 0.02), even though
gastrin
concentrations only increased to 71.2+/-6.6 pmol per liter. No effect, however, was noted on glucose disposal. 15.6 ng
gastrin
per kg given i.v. 30 min before an i.v. glucose tolerance test was without significant effect on the insulin response. The results indicate that
gastrin
can stimulate a rapid and short-lived release of insulin. In physiologic concentrations
gastrin
potentiates the glucose-stimulated insulin secretion and is without effect on basal insulin secretion. A small release of
gastrin
during oral glucose ingestion may to a limited extent contribute to the nonglycemic insulin secretion. During protein ingestion,
gastrin
probably stimulates insulin secretion significantly.
...
PMID:The effect of gastrin on basal- and glucose-stimulated insulin secretion in man. 470 28
Serum
gastrin
has been determined by radioimmunoassay in 13 subjects free of gastrointestinal disease, in the basal state, and following the intravenous injection of 1 mg glucagon. Serum
gastrin
fell from a mean +/-
SEM
level of 50.3 +/- 6.7 to 9.4 +/- 3.3 pg/ml at 30 minutes after injection, significant at p<0.005. This is similar to the response previously reported for secretin and indicates a role for glucagon in the control of
gastrin
release.
...
PMID:The effect of glucagon on serum gastrin. I. Studies in normal subjects. 471 11
The serum
gastrin
response to a standard protein meal has been determined in achlorhydric patients with atrophic gastritis and contrasted with the response in normal subjects whose gastric contents were kept continuously neutral by intragastric bicarbonate instillation. Five normal subjects showed a significant increase in serum
gastrin
from a mean (+/-
SEM
) of 17 +/- 3 pg/ml to 119 +/- 10 pg/ml but their response did not approach that of four patients with atrophic gastritis and antral sparing (605 +/- 133 pg/ml to 1418 +/- 186 pg/ml). By contrast, in four patients with antral gastritis, there was no significant change in
gastrin
levels (24 +/- 13 pg/ml to 55 +/- 19 pg/ml). These studies indicate that the
gastrin
-secreting cell mass is increased in atrophic gastritis with antral sparing and decreased in atrophic gastritis with antral involvement, as compared to the normal state. They provide further evidence for the existence in man of two distinct forms of atrophic gastritis.
...
PMID:The functional 'G' cell mass in atrophic gastritis. 503 89
Fasting serum
gastrin
has been measured by radioimmunoassay in 72 patients with duodenal ulcer and compared with that in normals, patients with gastric ulcer, and with the Zollinger-Ellison syndrome. The mean (+/-
SEM
)
gastrin
levels were 15.7 +/- 1.5 pg/ml in the duodenal ulcer group, 32.1 +/- 4.3 pg/ml in normals, 118 +/- 18.1 pg/ml in gastric ulcer, and between 450 and 2,000 pg/ml in the Zollinger-Ellison syndrome. There were no difficulties in distinguishing simple ulcer from the Zollinger-Ellison syndrome as the presence of hyperchlorhydria in combination with hypergastrinaemia led to a confident diagnosis of the latter disease.The effect of protein, glucose, and cream feeding with and without atropine was also assessed in a group of these patients with duodenal ulcer. As in normals, there was no stimulation of
gastrin
release by either atropine alone, distilled water, glucose, or cream. However, protein alone produced a greater rise in serum
gastrin
levels compared with that in normals and prior atropinization augmented this response greatly in duodenal ulcer. This indicates an increased amount of releasable
gastrin
in the latter disease, the release of which, under basal conditions, is suppressed by the high acidity in the antrum.
...
PMID:Serum gastrin in duodenal ulcer. I. Basal levels and effect of food and atropine. 513 20
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>